24/7 Biopharma.com – CDMO & Supplier Partnerships: How are relationships evolving to foster agility and innovation?

CDMO Partnerships Built on Flexibility, Innovation, Strategic Investment, Sustainability & True End-to-End Support

Abzena’s Chief of Staff and SVP of Global Supply Chain, Rhonda Gates, was recently featured in an article on 24/7 Biopharma.com that shared best practices that are helping CDMO & supplier partnerships succeed in today’s ever-changing market.

In an era where the pharmaceutical and biotech landscapes are rapidly evolving, the relationship between Contract Development and Manufacturing Organizations (CDMOs) and their suppliers is undergoing a significant transformation. During this year’s DCAT Week round table, industry leaders gathered to explore how these partnerships are being reshaped to enhance agility and drive innovation. As companies face increasing pressures to accelerate product development and navigate complex supply chain challenges, a collaborative approach has become essential. This article takes a closer look at the insights shared during the event, showcasing the essential strategies and best practices that are helping CDMO and supplier partnerships succeed in today’s ever-changing market.

Rhonda shared, “At Abzena, we’re moving beyond transactional interactions to create integrated, strategic CDMO and supplier relationships. As biopharma grows more complex, we build collaborative, trust-based alliances that enable agility and shared outcomes.

We engage earlier in product development to streamline supply chain design, capacity planning, and technology strategies, ensuring scalable solutions. This proactive collaboration invites our partners to drive innovation rather than execute actively.

By building a digitally connected network, we can leverage real-time visibility and synchronized planning—essential components for rapid, confident decisions. While ongoing, these efforts are critical to anticipating needs, responding to changes, and making data-driven improvements across the value chain.

Ultimately, agility emerges from alignment. When CDMOs and suppliers unite as seamless extensions of each other, we unlock new levels of performance. This synergy fuels our commitment to delivering high-quality therapies to patients—faster and more reliably.”

Access the full article here